Welcome to our dedicated page for Lazard news (Ticker: LAZ), a resource for investors and traders seeking the latest updates and insights on Lazard stock.
Lazard, Inc. reports developments in financial advisory and asset management, its two recurring business lines. The firm provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, while its asset management business offers investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals.
Recurring LAZ news includes quarterly operating results, monthly assets-under-management updates with flow, market, foreign-exchange and asset-class detail, common-stock dividend declarations, additions to advisory sector groups, and strategic updates for the global platform. Coverage also reflects the firm’s operations in North and South America, Europe, the Middle East, Asia and Australia.
Lazard, Inc. (NYSE: LAZ) reported its April 2024 Assets Under Management (AUM) at approximately $240.8 billion, with market depreciation of $4.4 billion, net outflows of $3.6 billion, and foreign exchange depreciation of $1.6 billion. The breakdown shows Equity at $187,582 million, Fixed Income at $45,399 million, and Other at $7,824 million.
Lazard, Inc. announced Michele Colocci joining as Vice Chairman, Investment Banking and Managing Director, Healthcare on June 3, 2024. With extensive experience in healthcare investment banking, Colocci's appointment aims to strengthen Lazard's global healthcare franchise. Lazard's EMEA business accounted for 40% of financial advisory revenues, showcasing its growth trajectory.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.